Replies to post #176300 on Biotech Values

[DewDiligence]

ENTA’s CSO, Dr. Yat Sun Or, sold 5K shares on 5/1/14 at an average price of about $37:

http://www.sec.gov/Archives/edgar/data/1177648/000090866214000166/xslF345X03/edgar.xml

The sale was under a 10b5-1 plan established in Feb 2014. Dr. Or continues to own 184K shares of ENTA, which is about $6.5M worth at the current market price.

Naturally, I would prefer that insiders not do any selling at all; however, the CEO and CSO have 10b5-1 plans, so they will presumably continue to sell modest amounts of stock on a regular basis if the share price exceeds the threshold specified in their respective plans.